Mechanisms of drug resistance in Mycobacterium tuberculosis.
about
Comparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from RussiaTargeting the chromosome partitioning protein ParA in tuberculosis drug discoveryRv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosisA Bayesian nonparametric model for spatially distributed multivariate binary data with application to a multidrug-resistant tuberculosis (MDR-TB) studyNative New Zealand plants with inhibitory activity towards Mycobacterium tuberculosis.Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, ChinaPhenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.Drug targets in mycobacterial sulfur metabolism.An update on the use of rifapentine for tuberculosis therapy.New targets and inhibitors of mycobacterial sulfur metabolism.Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis.Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?Role of mycobacterial efflux transporters in drug resistance: an unresolved question.Role of porins for uptake of antibiotics by Mycobacterium smegmatis.pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosisMolecular diagnostics in tuberculosis: basis and implications for therapy.Biochemistry of the non-mevalonate isoprenoid pathway.Navigating tuberculosis drug discovery with target-based screening.A systematic review of rapid drug susceptibility tests for multidrug-resistant tuberculosis using rifampin resistance as a surrogate.Rifapentine for the treatment of latent tuberculosis.Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation.Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean.Expedient synthesis of the heneicosasaccharyl mannose capped arabinomannan of the Mycobacterium tuberculosis cellular envelope by glycosyl carbonate donors.Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach.A genome-wide analysis of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis Beijing genotype.Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.A Versatile Synthesis of Pentacosafuranoside Subunit Reminiscent of Mycobacterial Arabinogalactan Employing One Strategic Glycosidation Protocol.Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
P2860
Q28486275-BBE0A36D-A1C6-4DCA-9AED-B9F7580F7895Q28486773-4815E1FA-362C-45EF-AA3B-2B5E618FCD02Q28487296-D542B623-6541-4BF9-AA12-76D626BA75BDQ30833918-3418E448-6A1F-4C18-830F-80373F8ED349Q33600394-AD0BE673-7C13-43AB-9215-425F145DD229Q33676299-BF62C164-22B6-4062-84C2-0F9A36FAA8A6Q33836636-2B7403FB-421E-43E4-8C1D-9826015F14E6Q34017127-E3FF2E0A-8DF9-4501-835F-572BABD6B65EQ35020400-34E7C390-9EBA-4314-850F-BDBF8DFDCB49Q35084363-A2CBA7CE-E447-4740-ACB7-A85B870BED51Q35095367-2EE32C2E-1A99-49D0-99C9-B4BEEA230BEFQ35127412-1638D2A2-CC09-40F7-92EC-B2A9B314EA5DQ35718261-390EB6A8-A76B-4058-A1EA-E293F05B8CBEQ36080072-3BC77128-C5D4-444E-8BA3-0D3A27AE9D53Q36157986-6D855EB5-DEB4-4C89-8CDD-CEB8AE639FB9Q36378353-97AB3543-7923-404D-9281-29ECD837EE61Q36870855-84125FF3-98C2-483E-A011-F8E710E0AA56Q37127014-1E6EC1CE-1C01-4564-AC27-739D330CF278Q37215691-CE3D023B-FCAD-4340-880C-006647D12530Q37570447-7C2A056A-FBF1-496D-ACDD-ED506DAEB1FBQ37899789-1470058B-1A84-4384-995B-9AF19D393B32Q38014956-77563A27-53AF-4BA9-8D60-017F9BB00EB7Q38088848-0BCA0900-8DB6-4D1E-8179-E42788CE214CQ38933165-63EE8D16-9D7A-4C34-8CD1-DDC0D55EBA95Q39990545-51677EEE-2C92-4726-A80A-4BDEA3161608Q41932850-EECE75CD-A2B3-4CCD-8049-B8665C315F5FQ41995806-69EF2615-A8BF-47E8-B86C-3EEBECB5E4ADQ42290950-57253601-FE40-4C6D-BF72-94853774ADDCQ43149039-4B19C023-C37E-4CB0-B972-5806BFC465D5Q44391212-87ABB772-9392-45CC-B3E8-8CC60937C7A0Q45209959-97F389EC-1C3F-4278-B183-5B9B6CAAF6B6Q48619449-45B9CB91-B323-450A-8802-03D37C98F3FBQ53379436-F8B932DF-C5EF-4689-8F08-32ED6A25BF49
P2860
Mechanisms of drug resistance in Mycobacterium tuberculosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Mechanisms of drug resistance in Mycobacterium tuberculosis.
@ast
Mechanisms of drug resistance in Mycobacterium tuberculosis.
@en
type
label
Mechanisms of drug resistance in Mycobacterium tuberculosis.
@ast
Mechanisms of drug resistance in Mycobacterium tuberculosis.
@en
prefLabel
Mechanisms of drug resistance in Mycobacterium tuberculosis.
@ast
Mechanisms of drug resistance in Mycobacterium tuberculosis.
@en
P356
P1476
Mechanisms of drug resistance in Mycobacterium tuberculosis.
@en
P2093
Mary Margaret Wade
Ying Zhang
P304
P356
10.2741/1289
P577
2004-01-01T00:00:00Z